Javier Nunez-Vicandi

Javier Nunez-Vicandi is a Partner at Sofinnova Partners. He joined the firm in 2022 and is a member of the Digital Medicine Strategy. Javier invests in companies at the intersection of healthcare and technology. He serves as a board observer at Latent Labs, Bioptimus, Cure51, Deepc, and Kiro.

In addition to his investment activities, Javier co-built and helps lead the development of Sofia, Sofinnova’s proprietary AI platform, which supports investment decisions and scientific analysis for the firm. He also played a key role in bringing a founder-facing version of Sofia to portfolio companies through the firm’s collaboration with Amazon Web Services (AWS) and NVIDIA.

Javier began his career as a practicing clinical doctor at Oxford University Hospital Trust in the UK, holding posts at Britain’s National Spinal Injury Centre and Oxford’s Churchill Hospital Transplant Department, the largest pancreatic transplant center in Europe.

He then moved into venture capital as an Analyst at the New Businesses Fund at M Ventures, working on investments in data-driven healthcare, biotechnology, and automation. He went on to become the first employee at Heal Capital, a €100 million early-stage HealthTech venture capital fund, where he helped grow the fund from zero to 12 investments, before joining Sofinnova.

Javier holds an MPhil (distinction) from Cambridge University and a Bachelor of Medicine, Bachelor of Surgery (MBBS) from Newcastle University.